What RAPS Convergence 2025 Means for Sponsors Preparing Global Submissions
It was wonderful to connect with so many of our peers at RAPS Convergence 2025 in Pittsburgh. As...
Accelerating Patient-Centric Trials: A Sponsor Checklist for Science-Based Planning
Learn how our patient-centric approach helps sponsors streamline development and reduce trial...
Why Regulatory Publishing Expertise is Essential for Neurology Clinical Trials
Developing treatments for neurological, psychiatric, or CNS disorders means navigating complex...
Advancing Dose Escalation Strategies with Bayesian Modeling
Learn how our biostatistics and strategic consulting teams collaborated with our biotechnology...
3 Reasons Why You Need to Consider a CRO That Excels in Oncology Regulatory Publishing
In oncology drug development, every day counts. Patients are waiting, trials are complex, and the...
Advancing Oncology Innovation with Adaptive Trial Designs
Learn how our strategic and regulatory team was able to work with a biopharmaceutical sponsor to...
Monthly FDA Guidance and Regulatory News Review - August 2025
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Single-Arm Studies: A Strategic Path to Oncology Drug Approval
In oncology drug development, randomized controlled trials (RCTs) are the gold standard for...
IND Success Strategy: Building a High-Quality IND from Scratch with Strategic Gap Analysis
Learn how our regulatory affairs team was able to work with a sponsor to build a complete,...
Trends in Oncology Regulation: FDA Draft Guidance on OS and Radiopharmaceuticals
Over the past two decades, the FDA has steadily increased the number of guidance documents it...